Drug profile · INN
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
CERVARIX
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) (CERVARIX) is a biological vaccine - induces immune response.
EMA: approved Antiinfectives for systemic use (J07) J07BM02
Patents linked 0
Pipeline programs 12
News articles 0
Drug details — human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 12
- Data quality
- 0.83
Quick answer
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) (CERVARIX) is a biological vaccine - induces immune response.
Key facts
INN human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
Brand CERVARIX
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BM02
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)?
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) (CERVARIX) is a biological vaccine - induces immune response.
What is the brand name for human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)?
CERVARIX is a marketed brand name for human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.